The parathyroid hormone 2 (PTH2) receptor

Area of Science:

• Endocrinology
• Neuroscience
• Molecular Biology

Background:

• The parathyroid hormone 2 (PTH2) receptor is a G protein-coupled receptor involved in various physiological processes.
• While parathyroid hormone (PTH) activates the PTH1 receptor, its interaction with the PTH2 receptor is less potent.
• The discovery of tuberoinfundibular peptide of 39 residues (TIP39) suggests a potential natural ligand for the PTH2 receptor.

Purpose of the Study:

• To investigate the ligand binding and activation properties of the human PTH2 receptor.
• To compare the activity of TIP39 and PTH on the PTH2 receptor.
• To elucidate the distribution and potential functions of the PTH2 receptor in the human body.

Main Methods:

• Ligand binding assays to determine affinity and potency.
• Second messenger assays (cAMP and intracellular calcium) to assess receptor activation.
• In situ hybridization or immunohistochemistry to determine receptor distribution.

Main Results:

• The human PTH2 receptor is activated at high potency by TIP39 and PTH.
• Rat and zebrafish PTH2 receptors are activated more weakly by PTH, supporting TIP39 as the natural ligand.
• The PTH2 receptor shows minimal interaction with parathyroid hormone-related peptide (PTHrP).
• Receptor activation is strongly coupled to cAMP accumulation and weakly to intracellular calcium increases.
• The PTH2 receptor is predominantly expressed in the nervous system (cerebral cortex, basal ganglia, septum, thalamus, hypothalamus, spinal cord) and pancreatic islet somatostatin cells.

Conclusions:

• TIP39 is likely the endogenous ligand for the human PTH2 receptor.
• The PTH2 receptor's signaling involves cAMP and calcium pathways.
• The widespread distribution in the nervous system suggests roles in neuroendocrine function and pain modulation.
• Peripheral expression in pancreatic islets indicates potential roles in metabolic regulation.